has reported Standalone financial results for the period ended March 31, 2025.
Financial Results (Q4 FY2025) - QoQ Comparison
The company has reported total income of Rs. 61.330 crores during the period ended March 31, 2025 as compared to Rs. 76.347 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs. 6.583 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. 31.990 crores for the period ended December 31, 2024.
The company has reported EPS of Rs. 0.98 for the period ended March 31, 2025 as compared to Rs. 4.74 for the period ended December 31, 2024.
Total Income | ₹ 61.330 crs | ₹76.347 crs | -19.67% |
Net Profit | ₹6.583 crs | ₹31.990 crs | -79.42% |
EPS | ₹0.98 | ₹4.74 | -79.32% |
Financial Results (Q4 FY2025) - YoY Comparison The company has reported total income of Rs. 61.330 crores during the period ended March 31, 2025 as compared to Rs.45.973 crores during the period ended March 31, 2024.
The company has posted net profit / (loss) of Rs.6.583 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.3.549 crores for the period ended March 31, 2024.
The company has reported EPS of Rs.0.98 for the period ended March 31, 2025 as compared to Rs.0.54 for the period ended March 31, 2024.
Total Income | ₹ 61.330 crs | ₹45.973 crs | 33.40% |
Net Profit | ₹6.583 crs | ₹3.549 crs | 85.49% |
EPS | ₹0.98 | ₹0.54 | 81.48% |
Financial Results (Year Ended FY2025) - YoY Comparison The company has reported total income of Rs.276.906 crores during the Financial Year ended March 31, 2025 as compared to Rs.217.981 crores during the Financial Year ended March 31, 2024.
The company has posted net profit / (loss) of Rs.55.361 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.22.463 crores for the Financial Year ended March 31, 2024.
The company has reported EPS of Rs.8.22 for the Financial Year ended March 31, 2025 as compared to Rs.3.39 for the Financial Year ended March 31, 2024.
Total Income | ₹276.906 crs | ₹217.981 crs | 27.03% |
Net Profit | ₹55.361 crs | ₹22.463 crs | 146.45% |
EPS | ₹8.22 | ₹3.39 | 142.48% |
Source : Equity Bulls
Keywords
JagsonpalPharmaceuticals
Q4FY25
Q4FY2025
FY2025
ResultUpdate